IOT Lenses ’s Post

The 2024 International Myopia Conference may have ended, but we are just getting started in sharing more about the eye-opening studies we presented there.   We revealed news on the significant slowing of myopia progression in a Chinese population after six months of Diffusion Optics Technology (DOT) spectacle lens wear* plus new interim data from a U.S. study on the absence of a rebound effect following the cessation of DOT lens wear**.   Over the coming weeks, SightGlass Vision will bring you insights from real world analysis gathered from practices in China and Canada, explore the performance of DOT in younger patients, and share further in-depth science around the use of contrast management to control myopia.   *Chen et al. Control of Myopia using Diffusion Optics Technology (DOT) spectacle lenses in a Chinese population: 6-month results. International Myopia Conference 2024. *Hill et al. Myopia progression after cessation of Diffusion Optics Technology (DOT) spectacle lenses. International Myopia Conference 2024. #MyopiaManagement #MyopiaControl #IMC2024

I am excited to announce that I presented at the KITE Research Rounds! 🎉 Thanks, Dr. Milos Popovic and Dr. Babak Taati for the invitation. I delved into the innovative world of ultrasound imaging for hybrid exoskeleton and noninvasive neuroprosthetic control, focusing on the following groundbreaking areas: 1. Hybrid Exoskeleton Control: a new ultrasound-based approach to sense muscle's fatigued state during FES for knee assistance 2. Voluntary Effort Prediction: Using ultrasound techniques to predict user intent and effort accurately with a cable-driven ankle exoskeleton. 3. Tremor Suppression: Utilizing ultrasound imaging to effectively suppress wrist tremors with below motor-threshold stimulation #KITEResearchRounds #UltrasoundImaging #ExoskeletonControl #VoluntaryEffortPrediction #TremorSuppression #AssistiveTechnology #Innovation Feel free to contact me if you have any questions or if you'd like to discuss this topic further.

Curious about photobiomodulation's role in combating long COVID? Tune in to Roger Seheult, MD of MedCram as he shares expert insights and research findings in his latest video! Watch here: https://lnkd.in/eeXYbDbJ #Neuronic #Neurofeedback #Photobiomodulation #LongCOVID

🕰️ A New Chapter Unveiled: The Antikythera Device Rediscovered! 🕰️ Recent scholarly endeavors have unearthed what seems to be a new chapter in the saga of the Antikythera mechanism. Ancient blueprints that allude not just to a device far ahead of its time but to its application in realms we've only recently ventured into! This revelation isn't just a testament to the ingenuity of our ancestors; it serves as a bridge connecting the dots between past and present, showcasing a lineage of innovation that spans centuries. It suggests that the Antikythera mechanism's applications laid the groundwork for technologies today. As we stand on the shoulders of giants, let's dive deeper into how ancient wisdom is shaping future frontiers. Discover how VRpatients is harnessing the spirit of innovation to revolutionize medical training and education. Embrace the journey through time and technology at vrpatients.com – where history meets the future of healthcare. Also, happy April 1st. 😜 #Innovation #History #VirtualReality #MedicalSimulation #VRpatients #TechnologyEvolution #AprilFools

The first European study on myopia management treatment combining DIMS spectacle lenses and 0.01% low-dose atropine has been published. This new scientific study conducted by Prof. Paolo Nucci and Doctor Andrea Lembo, in collaboration with leading researchers in the field,  confirmed the efficacy of 0.01% atropine and MiYOSMART spectacle lenses with D.I.M.S. Technology in slowing down the myopia progression on their own. The slow down effect increases further when they are prescribed in combination. "We are extremely proud to reveal the first European study on the efficacy of MiYOSMART spectacle lenses in combination with 0.01% low dose atropine the Caucasian population: a wonderful teamwork that confirms the efficacy of DIMS spectacle lenses in slowing down the progression of myopia in European children." explains Dr. Andrea Lembo. Read the full article here: https://lnkd.in/ew5J-nwP #hoyaforthevisionaries #miyosmart #myopiamanagement

The digest is out! Check your inboxes for the latest on orthokeratology from Menicon. In this edition, we delve into the newest ortho-k insights, featuring Menicon’s IMC research highlights, new study summaries and upcoming webinars! Let's get started with The Menicon IMC 2024 showcase: ortho-k efficacy, safety and ocular changes This article provides an overview of Menicon’s contributions to the International Myopia Conference 2024, with eight scientific abstracts highlighting their research in ortho-k and its efficacy, safety, and effects on ocular structures. Pictured are some of the abstract authors, from left to right: Keiji Sugimoto, Dr. Jacinto Santodomingo, Chie Suzuki, Yui Kahara, Bariah Mohd Ali, Takahiro Hiraoka, Hikaru Asai and Asaki Suzaki. https://lnkd.in/g9qtzvSB PS. Not subscribed yet? Sign up for the Myopia Profile Digest and explore all our themed learning editions through the footer of any page on myopiaprofile.com! #myopia #myopiacontrol #myopiamanagement #professionallearning

"STIR, 𝐄𝐏𝐈, 𝐕𝐈𝐁𝐄, 𝐃𝐈𝐗𝐎𝐍, 𝐚𝐧𝐝 𝐬𝐨 𝐨𝐧... 𝐖𝐡𝐚𝐭??? 𝐖𝐡𝐚𝐭 𝐢𝐬 𝐭𝐡𝐚𝐭??" 🙄 I got you! 𝐿𝑒𝑡 𝑚𝑒 𝑒𝑥𝑝𝑙𝑎𝑖𝑛 𝑡𝑜 𝑦𝑜𝑢 𝑤ℎ𝑎𝑡 𝑎𝑙𝑙 𝑡ℎ𝑜𝑠𝑒 𝑚𝑒𝑎𝑛, 𝑎𝑟𝑒, 𝑎𝑛𝑑 𝑑𝑜!!! 😎 It is 7:30 pm Sunday, and you already know what that means... I am thrilled to share yet another valuable resource with the MRI community! I've put together a carousel about all things STIR, from the physics of the sequence to its applications and some beautiful images of course. This is a basic guide as STIR is a very complex sequence. In this carousel series, I will explore some of the most amazing sequences we have in MRI. I will approach this with a vendor-neutral view and bring you some super cool images as well. MRI sequences and their specific vendor names are something that often puts radiographers in a state of confusion, but that must change. Don't let a pompous name scare you. Let's discover together, what they mean, what they do, and most importantly for us radiographers, how they look like! Join me, on this journey. The future is today! 😍 🎡 𝙎𝙬𝙞𝙥𝙚 𝙩𝙝𝙧𝙤𝙪𝙜𝙝 𝙩𝙝𝙚 𝙘𝙖𝙧𝙤𝙪𝙨𝙚𝙡 𝙛𝙤𝙧 𝙖 𝙙𝙚𝙚𝙥 𝙙𝙞𝙫𝙚 𝙞𝙣𝙩𝙤 𝐭𝐡𝐞 𝐰𝐨𝐫𝐥𝐝 𝐨𝐟 STIR 𝐬𝐞𝐪𝐮𝐞𝐧𝐜𝐞! 👉 𝙔𝙤𝙪𝙧 𝙚𝙭𝙥𝙚𝙧𝙩𝙞𝙨𝙚 𝙢𝙖𝙩𝙩𝙚𝙧𝙨, 𝙖𝙣𝙙 𝙄 𝙞𝙣𝙫𝙞𝙩𝙚 𝙮𝙤𝙪 𝙩𝙤 𝙨𝙝𝙖𝙧𝙚 𝙖𝙙𝙙𝙞𝙩𝙞𝙤𝙣𝙖𝙡 𝙩𝙞𝙥𝙨 𝙖𝙣𝙙 𝙩𝙧𝙞𝙘𝙠𝙨 𝙞𝙣 𝙩𝙝𝙚 𝙘𝙤𝙢𝙢𝙚𝙣𝙩𝙨, that i might have forgotten. 𝙇𝙚𝙩'𝙨 𝙛𝙤𝙨𝙩𝙚𝙧 𝙖 𝙘𝙤𝙡𝙡𝙖𝙗𝙤𝙧𝙖𝙩𝙞𝙫𝙚 𝙨𝙥𝙖𝙘𝙚 𝙛𝙤𝙧 𝙡𝙚𝙖𝙧𝙣𝙞𝙣𝙜 𝙖𝙣𝙙 𝙞𝙢𝙥𝙧𝙤𝙫𝙚𝙢𝙚𝙣𝙩. 𝐅𝐨𝐥𝐥𝐨𝐰 for more insights and carrousels (Sunday, 7:30 pm London, UK) on other topics, and don't forget to 𝐒𝐡𝐚𝐫𝐞 this carousel with your network. 🔄 The more we share, the more lives we impact. 🌐💙 𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝑠 𝑢𝑠𝑒𝑑: Radiopedia.org mriquestions.com mrimaster.com #MRI #MRIsafety #Patientsafety #MRIinnovations #ContinuousLearning #STIR #MRIsequences #moreefficiency #patientexperience #everythingmri #patientsafety #fatsat #mrifatsaturation

More possibilities to address the emerging needs in myopia management, with innovative technologies.

At the International Myopia Conference today, SightGlass Vision, Inc. shared six-month data reporting from the CATHAY trial—a two-year, randomized, controlled study across five hospitals in China. ‘Control of Myopia Using Diffusion Optics Technology Spectacle Lenses in a Chinese Population: 6-Month Results’ (Chen Z, et al.) evaluated 186 participants after six months of wear, demonstrating that DOT lenses significantly slowed myopia progression as evidenced by minimal change in axial length and cycloplegic refractive error compared to control group*. Find out more about the CATHAY trial from Debbie Laughton BSc(Hons) MCOptom PhD FBCLA, Director of Medical Affairs at SightGlass Vision. *Chen et al. Control of Myopia using Diffusion Optics Technology (DOT) spectacle lenses in a Chinese population: 6-month results. To be presented at International Myopia Conference 2024. #IMC2024 #MyopiaManagement #MyopiaControl

[𝐓𝐞𝐥𝐞𝐫𝐞𝐡𝐚𝐛𝐢𝐥𝐢𝐭𝐚𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐩𝐨𝐬𝐭-𝐬𝐭𝐫𝐨𝐤𝐞 𝐬𝐮𝐛𝐣𝐞𝐜𝐭𝐬 : 𝐟𝐞𝐚𝐬𝐢𝐛𝐢𝐥𝐢𝐭𝐲 𝐬𝐭𝐮𝐝𝐲] Prof. Thierry Lejeune's team recently conducted a feasibility study entitled ‘𝑇𝑒𝑙𝑒𝑟𝑒ℎ𝑎𝑏𝑖𝑙𝑖𝑡𝑎𝑡𝑖𝑜𝑛 𝑓𝑜𝑟 𝑝𝑜𝑠𝑡-𝑠𝑡𝑟𝑜𝑘𝑒 𝑠𝑢𝑏𝑗𝑒𝑐𝑡𝑠’, which included one of our devices in development, the REAtouch® Home. This work was presented in the form of a poster at ESPRM in Ljubljana. Here's a summary. #Axinesis #telerehabilitation #stroke #REAtouchHome #feasabilitystudy